Evidence map›Paper›PMID 31145834›Full record

ReviewCancer2019

GIScience and cancer: State of the art and trends for cancer surveillance and epidemiology.

Liora Sahar, Stephanie L Foster, Recinda L Sherman, Kevin A Henry, Daniel W Goldberg, David G Stinchcomb, Joseph E Bauer

Open access · bronzeAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 90 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Geospatial Science for the Environmental Epidemiology of Cancer in the Exposome Era.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 1 country.

Liora SaharGeospatial Research, Statistics and Evaluation Center, American Cancer Society, Atlanta, Georgia.ORCID 0000-0001-8365-4648
Stephanie L FosterGeospatial Research Analysis and Services Program, Centers for Disease Control and Prevention, Atlanta, Georgia.
Recinda L ShermanData Use and Research, North American Association of Central Cancer Registries, Springfield, Illinois.
Kevin A HenryDepartment of Geography and Urban Studies, Temple University, Philadelphia, Pennsylvania.
Daniel W GoldbergDepartment of Geography, College of Geosciences, Texas A&M University, College Station, Texas.
David G StinchcombHealth Studies, Westat, Rockville, Maryland.
Joseph E BauerStatistics and Evaluation Center, American Cancer Society, Atlanta, Georgia.
American Cancer Society · USCenters for Disease Control and Prevention · USFox Chase Cancer Center · USNorth American Association of Central Cancer Registries · USTexas A&M University · USWestat (United States) · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Maps are well recognized as an effective means of presenting and communicating health data, such as cancer incidence and mortality rates. These data can be linked to geographic features like counties or census tracts and their associated attributes for mapping and analysis. Such visualization and analysis provide insights regarding the geographic distribution of cancer and can be important for advancing effective cancer prevention and control programs. Applying a spatial approach allows users to identify location-based patterns and trends related to risk factors, health outcomes, and population health. Geographic information science (GIScience) is the discipline that applies Geographic Information Systems (GIS) and other spatial concepts and methods in research. This review explores the current state and evolution of GIScience in cancer research by addressing fundamental topics and issues regarding spatial data and analysis that need to be considered. GIScience, along with its health-specific application in the spatial epidemiology of cancer, incorporates multiple geographic perspectives pertaining to the individual, the health care infrastructure, and the environment. Challenges addressing these perspectives and the synergies among them can be explored through GIScience methods and associated technologies as integral parts of epidemiologic research, analysis efforts, and solutions. The authors suggest GIScience is a powerful tool for cancer research, bringing additional context to cancer data analysis and potentially informing decision-making and policy, ultimately aimed at reducing the burden of cancer.

Indexed as

Epidemiological MonitoringGeographic Information SystemsHumansNeoplasmscancer surveillancegeographic information science (GIScience)Geographic Information Systems (GIS)mapping and visualizationspatial epidemiologyspatial statistics

Identifiers

PMID31145834
PMCPMC6625915
OpenAlexW2947586316

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.